Informação sobre produto
- Hydrazinecarboxamide, N-(2,6-dichloro-4-pyridinyl)-2-[1,3-dimethyl-4-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-
- N-(2,6-Dichloropyridin-4-yl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazinecarboxamide
JTE 013 is a medicinal compound that acts as an inhibitor of kinases, which are enzymes involved in cell cycle regulation and tumor growth. It has been shown to induce apoptosis, or programmed cell death, in cancer cells and has potential as an anticancer agent. JTE 013 has been tested on human cancer cell lines and found to be effective at inhibiting protein expression related to the growth of tumors. This compound has also been found in urine samples of Chinese patients with various forms of cancer, indicating its potential for use as a diagnostic tool. Overall, JTE 013 shows promise as a potent inhibitor of kinases for use in the treatment of cancer.
Propriedades químicas
Consulta técnica sobre: 3D-XWA75693 JTE 013
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
